Skip to content
Screener

Cue Biopharma CUE Q1 2026 earnings

Reported May 14, 2026 · Before market open

Revenue$5.7MBeat by $3.2M
EPS-$1.08Beat by $2.22
Revenue estimate$2.5M
EPS estimate-$3.30

Next report

Nov 11, 2026 (In 1 week)
Revenue estimate$1.0M
EPS estimate-$2.24

FAQ

When did Cue Biopharma report Q1 2026 earnings?
Cue Biopharma (CUE) reported Q1 2026 earnings on May 14, 2026 before market open.
What were Cue Biopharma's Q1 2026 revenue and EPS?
Cue Biopharma reported revenue of $5.7M and eps of $-1.08 for Q1 2026.
Did Cue Biopharma beat estimates in Q1 2026?
Revenue beat the consensus estimate of $2.5M by $3.2M. EPS beat the consensus estimate of $-3.30 by $2.22.
How did Cue Biopharma's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1250.6% from $421.0K a year earlier and eps declined 535.3% from $-0.17.
Where can I find Cue Biopharma's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-224101) and the 10-Q periodic report (0001193125-26-224091) directly on SEC EDGAR. The filing index links above go to sec.gov.